HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at

CATALENT, INC

Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com

JOHN CHIMINSKI

JOHN CHIMINSKI CHAIR & CHIEF EXECUTIVE OFFICER. John Chiminski was named Chief Executive Officer of Catalent Pharma Solutions in March 2009. He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.From 2007 to 2009, Mr. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business

CATALENT, INC

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the promotion of Thomas Castellano to serve as the company’s Senior Vice President and Chief Financial Officer effective June 1, 2021, succeeding Wetteny Joseph who

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

BATHGATE, UK

The Bathgate facility is an important part of our Clinical Supply Services cold chain network. With industry-leading expertise in project and materials management and controlled substance licensing, it is well suited to handle your specialty needs. HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at

CATALENT, INC

Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com

JOHN CHIMINSKI

JOHN CHIMINSKI CHAIR & CHIEF EXECUTIVE OFFICER. John Chiminski was named Chief Executive Officer of Catalent Pharma Solutions in March 2009. He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.From 2007 to 2009, Mr. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business

CATALENT, INC

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the promotion of Thomas Castellano to serve as the company’s Senior Vice President and Chief Financial Officer effective June 1, 2021, succeeding Wetteny Joseph who

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

BATHGATE, UK

The Bathgate facility is an important part of our Clinical Supply Services cold chain network. With industry-leading expertise in project and materials management and controlled substance licensing, it is well suited to handle your specialty needs. ALL GLOBAL CAREER OPPORTUNITIES You want to advance your career in a growing company. Over the last five years, Catalent has re-invested more than $2 billion back into the company and its people. You want to make a global impact! From North America to Europe, Asia to Latin America, we have DEVELOPING OPTIMAL FORMULATIONS Executive summary on API-sparing development techniques and identification of appropriate scalable formulation technology. WINDSOR, ONTARIO, CANADA Windsor, Ontario is one of two sites located in Canada offering softgel development and manufacturing capabilities for the Pharmaceutical and Consumer Health industries.

TABLETS & CAPSULES

Tablets & Capsules. Catalent is your trusted partner for your oral solid dose product needs, from clinical development through to commercial manufacturing. Our team has extensive experience in handling highly potent compounds including all U.S. Drug Enforcement CATALENT AGREES TO ACQUIRE DRY POWDER INHALER SPRAY DRYING SOMERSET, N.J. – January 13, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced it has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR), a

TOM CASTELLANO

Tom Castellano was named Senior Vice President & Chief Financial Officer in June 2021. Mr. Castellano previously served as Catalent’s Global Vice President of Operational Finance, providing finance partnership on strategic execution THE POST-COVID PIPELINE TAKES SHAPE Date: June 15, 2021 Time: 12:00PM EDT While the US COVID-19 outbreak may be on the verge of being contained, new variants and a multitude of pipeline problems is keeping this issue alive. DRUG DELIVERY INSTITUTE The Catalent Applied Drug Delivery Institute will promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators—thereby enhancing understanding of available, emerging and future drug delivery technologies, and improving patient care. STANDARDS OF BUSINESS CONDUCT 2021 ANNUAL COMPLIANCE CERTIFICATION. Catalent has established a comprehensive compliance program, applicable to all its direct and indirect subsidiaries, that is designed to prevent, detect and promptly address any instances of misconduct, in accord with the US Dept. of Health and Human Services’ Office of Inspector General’s “Compliance Program Guidance for Pharmaceutical SMARTAG® ANTIBODY DRUG CONJUGATE TECHNOLOGY Summary: The SMARTag® Antibody Drug Conjugate technology platform offers ADC developers a new toolkit to develop optimized bioconjugates.Developed by Redwood Bioscience, the technology overcomes the limitations associated with conventional protein chemistries that produce heterogeneous products with variable conjugate potency, toxicity and stability. HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at

CATALENT, INC

Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com

JOHN CHIMINSKI

JOHN CHIMINSKI CHAIR & CHIEF EXECUTIVE OFFICER. John Chiminski was named Chief Executive Officer of Catalent Pharma Solutions in March 2009. He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.From 2007 to 2009, Mr. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business

CATALENT, INC

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the promotion of Thomas Castellano to serve as the company’s Senior Vice President and Chief Financial Officer effective June 1, 2021, succeeding Wetteny Joseph who

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

BATHGATE, UK

The Bathgate facility is an important part of our Clinical Supply Services cold chain network. With industry-leading expertise in project and materials management and controlled substance licensing, it is well suited to handle your specialty needs. HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at

CATALENT, INC

Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com

JOHN CHIMINSKI

JOHN CHIMINSKI CHAIR & CHIEF EXECUTIVE OFFICER. John Chiminski was named Chief Executive Officer of Catalent Pharma Solutions in March 2009. He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.From 2007 to 2009, Mr. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business

CATALENT, INC

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the promotion of Thomas Castellano to serve as the company’s Senior Vice President and Chief Financial Officer effective June 1, 2021, succeeding Wetteny Joseph who

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

BATHGATE, UK

The Bathgate facility is an important part of our Clinical Supply Services cold chain network. With industry-leading expertise in project and materials management and controlled substance licensing, it is well suited to handle your specialty needs. ALL GLOBAL CAREER OPPORTUNITIES You want to advance your career in a growing company. Over the last five years, Catalent has re-invested more than $2 billion back into the company and its people. You want to make a global impact! From North America to Europe, Asia to Latin America, we have DEVELOPING OPTIMAL FORMULATIONS Executive summary on API-sparing development techniques and identification of appropriate scalable formulation technology. WINDSOR, ONTARIO, CANADA Windsor, Ontario is one of two sites located in Canada offering softgel development and manufacturing capabilities for the Pharmaceutical and Consumer Health industries.

TABLETS & CAPSULES

Tablets & Capsules. Catalent is your trusted partner for your oral solid dose product needs, from clinical development through to commercial manufacturing. Our team has extensive experience in handling highly potent compounds including all U.S. Drug Enforcement CATALENT AGREES TO ACQUIRE DRY POWDER INHALER SPRAY DRYING SOMERSET, N.J. – January 13, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced it has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR), a

TOM CASTELLANO

Tom Castellano was named Senior Vice President & Chief Financial Officer in June 2021. Mr. Castellano previously served as Catalent’s Global Vice President of Operational Finance, providing finance partnership on strategic execution THE POST-COVID PIPELINE TAKES SHAPE Date: June 15, 2021 Time: 12:00PM EDT While the US COVID-19 outbreak may be on the verge of being contained, new variants and a multitude of pipeline problems is keeping this issue alive. DRUG DELIVERY INSTITUTE The Catalent Applied Drug Delivery Institute will promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators—thereby enhancing understanding of available, emerging and future drug delivery technologies, and improving patient care. STANDARDS OF BUSINESS CONDUCT 2021 ANNUAL COMPLIANCE CERTIFICATION. Catalent has established a comprehensive compliance program, applicable to all its direct and indirect subsidiaries, that is designed to prevent, detect and promptly address any instances of misconduct, in accord with the US Dept. of Health and Human Services’ Office of Inspector General’s “Compliance Program Guidance for Pharmaceutical SMARTAG® ANTIBODY DRUG CONJUGATE TECHNOLOGY Summary: The SMARTag® Antibody Drug Conjugate technology platform offers ADC developers a new toolkit to develop optimized bioconjugates.Developed by Redwood Bioscience, the technology overcomes the limitations associated with conventional protein chemistries that produce heterogeneous products with variable conjugate potency, toxicity and stability. HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. ALL GLOBAL CAREER OPPORTUNITIES You want to advance your career in a growing company. Over the last five years, Catalent has re-invested more than $2 billion back into the company and its people. You want to make a global impact! From North America to Europe, Asia to Latin America, we have

OUR LOCATIONS

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives. DRUG DELIVERY INSTITUTE The Catalent Applied Drug Delivery Institute will promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators—thereby enhancing understanding of available, emerging and future drug delivery technologies, and improving patient care.

WINCHESTER, USA

Winchester, USA. Catalent’s Winchester location is the flagship US manufacturing location for large scale oral dose forms, with integrated analytical and development services. With 28 years of expertise in product development, technology transfers and commercial manufacturing, and roots in industry-leading Glatt technology.

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

HOME - CATALENTCAREERSORAL DOSEBIOLOGICSSPECIALTYCLINICAL

SUPPLYCONSUMER

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives. Learn More. Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies. Working on 80+ compounds for 60+ customers across our global network.

Learn

CAREERS - CATALENT

Catalent is a global, high-growth, public company and a leading partner for the pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide. Your talents, ideas, and passion are essential to our mission: to help people live better, healthier lives. ALL GLOBAL CAREER OPPORTUNITIES You want to advance your career in a growing company. Over the last five years, Catalent has re-invested more than $2 billion back into the company and its people. You want to make a global impact! From North America to Europe, Asia to Latin America, we have

OUR LOCATIONS

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.

SIGN IN - CATALENT

Sign in with your organizational account. This computer system and associated networks are solely for the business use of Catalent Pharma Solutions’ authorized users. The company’s computers, software and proprietary data and information stored on them remain at VISION, MISSION & VALUES Our Values Define Us. Our VISION is to be the world’s most trusted, reliable and innovative drug development and delivery partner by upholding the highest industry standards and exceeding customer expectations while driving strong, sustained growth for the company.. Our MISSION is to develop, manufacture and supply products that help people live better, healthier lives. DRUG DELIVERY INSTITUTE The Catalent Applied Drug Delivery Institute will promote innovation, knowledge-sharing and collaboration between industry leaders, academic experts, customers and regulators—thereby enhancing understanding of available, emerging and future drug delivery technologies, and improving patient care.

WINCHESTER, USA

Winchester, USA. Catalent’s Winchester location is the flagship US manufacturing location for large scale oral dose forms, with integrated analytical and development services. With 28 years of expertise in product development, technology transfers and commercial manufacturing, and roots in industry-leading Glatt technology.

BALTIMORE, USA

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in the city of Baltimore, MD, specializes in upstream and

downstream process

GOSSELIES, BELGIUM

Our European Center of Excellence in cell therapy at Gosselies, Belgium includes a 25,830 sq. ft. Clinical Manufacturing facility and a 41,000 sq. ft. purpose-built CGxP facility offering advanced clinical and commercial supply. An additional large-scale 60,000 sq. ft. commercial dedicated plant is currently under construction and

expected to

SITE TOURS - CATALENT In this 360° Virtual Tour, explore Catalent’s Aprilia facility. This site, located in Europe, is a center of excellence for softgel development and manufacturing for both oral and topical dose forms. This site features innovative technologies for Pharmaceuticals, Over

OUR LOCATIONS

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs. DEVELOPING OPTIMAL FORMULATIONS Executive summary on API-sparing development techniques and identification of appropriate scalable formulation technology.

HPAPI SUMMIT USA

FEATURED SPEAKER . Andy Maitland Director Operations and Supply Chain, Catalent . Session Title: High Potency Containment from Early Stage to Commercial Scale Micronization Session Date: Thursday, June 24, 2021 Session Time: 10:45AM – 11:15AM EDT Abstract: As the development of highly potent molecules becomes more prevalent in the small molecule R&D pipeline, there are numerous WINDSOR, ONTARIO, CANADA Windsor, Ontario is one of two sites located in Canada offering softgel development and manufacturing capabilities for the Pharmaceutical and Consumer Health industries.

TOM CASTELLANO

Tom Castellano was named Senior Vice President & Chief Financial Officer in June 2021. Mr. Castellano previously served as Catalent’s Global Vice President of Operational Finance, providing finance partnership on strategic execution STANDARDS OF BUSINESS CONDUCT 2021 ANNUAL COMPLIANCE CERTIFICATION. Catalent has established a comprehensive compliance program, applicable to all its direct and indirect subsidiaries, that is designed to prevent, detect and promptly address any instances of misconduct, in accord with the US Dept. of Health and Human Services’ Office of Inspector General’s “Compliance Program Guidance for Pharmaceutical THE POST-COVID PIPELINE TAKES SHAPE Date: June 15, 2021 Time: 12:00PM EDT While the US COVID-19 outbreak may be on the verge of being contained, new variants and a multitude of pipeline problems is keeping this issue alive.

RICCI WHITLOW

Ricci Whitlow was named President, Clinical Supply Services in January 2020. She rejoins Catalent after two-and-a-half years, having previously held the position of VP Operations, overseeing nine manufacturing facilities across North and South America.

PRODUCT LIBRARY

We proudly help launch countless new products while driving brand growth and market share for a diverse portfolio of global clients. With a vast offering of development capabilities, global manufacturing and regulatory services, our solutions are comprehensive. Explore our product library below to find yours. SIGN UP NOW TO STAY CURRENT WITH THE LATEST NEWS AND INSIGHTS

SUBSCRIBE NOW

SIGN UP NOW TO STAY CURRENT WITH THE LATEST NEWS AND INSIGHTS

SUBSCRIBE NOW

×

* Oral Dose

* Development & Bioavailability * Preclinical Development

* Formulation

* Bioavailability Enhancement * Integrated Development Solutions

* Dose Form Design

* Better Treatments by Design * Tablets & Capsules * Orally Disintegrating Tablets * Softgel Technology

* Stick Pack

* Softgel Technologies * RP Scherer Softgel Technology * Plant Based Softgel Technology * Oral Macromolecule Delivery * Abuse Deterrent Technology * Smaller Easy to Swallow Softgels * Oral Manufacturing * Commercial Manufacturing * Scale-Up & Product Launch * Technology Transfers

* OneXpress™

* Oral Dose Packaging * Oral Dose Analytical Solutions * Solid State Screening * Methods Development & Validation * Stability Testing & Storage

* Biologics

* Biologics Development * Advanced Therapeutics

* Specialty

* Technologies

* Specialty

* Inhalation

* Inhalation Development & Analytical * Metered Dose Inhalers

* Nasal Sprays

* Dry Powder Inhalers * Development & Analytical Services * Small Molecule Injectable * Regulatory Support Services

* Orphan Drugs

* Clinical Supply

* Forecasting & Planning * Packaging Services * Comparator Sourcing * Distribution & Logistics

* Consumer

* Over-The-Counter

* Nutritional Supplements

* Beauty

* Product Library

* Expert Content

* Biologics

* Clinical Supply Services

* Consumer Health

* Cell Therapy

* Gene Therapy

* Development & Bioavailability

* Dose Form Design

* Oral Technologies

* Softgel Technologies * Oral Manufacturing * Small Molecule Analytical

* Inhalation

* Small Molecule Injectable

* Locations

* Asia Pacific

* Europe

* Latin America

* North America

* About Us

* Who We Are

* News & Events

* Our Leadership

* Our Scientists

* Investors

* Corporate Responsibility * Diversity & Inclusion

* Careers

* Overview

* Why Join Us?

* Career Opportunities

* Regional Sites

* China

* Japan

* Latin America

* Portuguese

* Spanish

*

Oral Dose

*

Development & Bioavailability * Preclinical Development

* Formulation

* Bioavailability Enhancement * Integrated Development Solutions

*

Dose Form Design

* Better Treatments by Design * Tablets & Capsules * Orally Disintegrating Tablets * Softgel Technology

* Stick Pack

*

Softgel Technologies * RP Scherer Softgel Technology * Plant Based Softgel Technology * Oral Macromolecule Delivery * Abuse Deterrent Technology * Smaller Easy to Swallow Softgels

*

Oral Manufacturing

* Commercial Manufacturing * Scale-Up & Product Launch * Technology Transfers

* OneXpress™

* Oral Dose Packaging

*

Oral Dose Analytical Solutions * Solid State Screening * Methods Development & Validation * Stability Testing & Storage

*

Biologics

* Biologics Development * Advanced Therapeutics

* Specialty

* Technologies

*

Specialty

*

Inhalation

* Inhalation Development & Analytical * Metered Dose Inhalers

* Nasal Sprays

* Dry Powder Inhalers * Development & Analytical Services * Small Molecule Injectable * Regulatory Support Services

* Orphan Drugs

*

Clinical Supply

* Forecasting & Planning * Packaging Services * Comparator Sourcing * Distribution & Logistics

*

Consumer

* Over-The-Counter

* Nutritional Supplements

* Beauty

* Product Library

*

Expert Content

* Biologics

* Clinical Supply Services

* Consumer Health

* Cell Therapy

* Gene Therapy

* Development & Bioavailability

* Dose Form Design

* Oral Technologies

* Softgel Technologies * Oral Manufacturing * Small Molecule Analytical

* Inhalation

* Small Molecule Injectable

*

Locations

* Asia Pacific

* Europe

* Latin America

* North America

*

About Us

* Who We Are

* News & Events

* Our Leadership

* Our Scientists

* Investors

* Corporate Responsibility * Diversity & Inclusion

*

Careers

* Overview

* Why Join Us?

* Career Opportunities

*

Regional Sites

* China

* Japan

* Latin America

* Portuguese

* Spanish

Contact Us

* Regional Sites

* China

* Japan

* Latin America

* Spanish

* Portuguese

*

Regional Sites

* China

* Japan

* Latin America

* Spanish

* Portuguese

Contact Us

* Oral

Dose

* Development & Bioavailability * Preclinical Development

* Formulation

* Bioavailability Enhancement * Integrated Development Solutions

* Dose Form Design

* Better Treatments by Design * Tablets & Capsules * Orally Disintegrating Tablets * Softgel Technology

* Stick Pack

* Oral Technologies

* Bioavailability Enhancement * Modified/Controlled-Release * Orally Disintegrating Tablets

* Abuse Deterrent

* Oral Macromolecule Delivery * Softgel Technologies * RP Scherer Softgel Technology * Plant Based Softgel Technology * Oral Macromolecule Delivery * Abuse Deterrent Technology * Smaller Easy to Swallow Softgels * Oral Manufacturing * Commercial Manufacturing * Scale-Up & Product Launch * Technology Transfers * OneXpress™ Solution * Oral Dose Packaging * Oral Dose Analytical Solutions * Solid State Screening * Methods Development & Validation * Stability Testing & Storage

* Biologics

* Biotherapeutics

* Advanced Therapeutics

* Specialty

* Technologies

* Specialty

* Inhalation

* Inhalation Development & Analytical * Metered Dose Inhalers

* Nasal Sprays

* Dry Powder Inhalers * Development & Analytical Services * Small Molecule Injectable * Regulatory Support Services

* Orphan Drugs

* Clinical

Supply

* Forecasting & Planning * Packaging Services * Comparator Sourcing * Distribution & Logistics

* Consumer

* Over-The-Counter

* Nutritional Supplements

* Beauty

* Product Library

* Expert

Content

* Biologics

* Clinical Supply Services

* Consumer Health

* Cell Therapy

* Gene Therapy

* Development & Bioavailability

* Dose Form Design

* Oral Technologies

* Softgel Technologies * Oral Manufacturing * Small Molecule Analytical

* Inhalation

* Small Molecule Injectable

* Locations

* Asia Pacific

* Europe

* Latin America

* North America

* Site Tours

* About Us

* Who We Are

* News & Events

* Our Leadership

* Our Scientists

* Investors

* Corporate Responsibility * Diversity & Inclusion

* Careers

* Working at Catalent

* Why Join Us?

* Career Opportunities

*

Oral

Dose

*

Development & Bioavailability * Preclinical Development

* Formulation

* Bioavailability Enhancement * Integrated Development Solutions

*

Dose Form Design

* Better Treatments by Design * Tablets & Capsules * Orally Disintegrating Tablets * Softgel Technology

* Stick Pack

*

Oral Technologies

* Bioavailability Enhancement * Modified/Controlled-Release * Orally Disintegrating Tablets

* Abuse Deterrent

* Oral Macromolecule Delivery

*

Softgel Technologies * RP Scherer Softgel Technology * Plant Based Softgel Technology * Oral Macromolecule Delivery * Abuse Deterrent Technology * Smaller Easy to Swallow Softgels

*

Oral Manufacturing

* Commercial Manufacturing * Scale-Up & Product Launch * Technology Transfers * OneXpress™ Solution * Oral Dose Packaging

*

Oral Dose Analytical Solutions * Solid State Screening * Methods Development & Validation * Stability Testing & Storage

*

Biologics

* Biotherapeutics

* Advanced Therapeutics

* Specialty

* Technologies

*

Specialty

*

Inhalation

* Inhalation Development & Analytical * Metered Dose Inhalers

* Nasal Sprays

* Dry Powder Inhalers * Development & Analytical Services * Small Molecule Injectable * Regulatory Support Services

* Orphan Drugs

*

Clinical

Supply

* Forecasting & Planning * Packaging Services * Comparator Sourcing * Distribution & Logistics

*

Consumer

* Over-The-Counter

* Nutritional Supplements

* Beauty

* Product Library

*

Expert

Content

* Biologics

* Clinical Supply Services

* Consumer Health

* Cell Therapy

* Gene Therapy

* Development & Bioavailability

* Dose Form Design

* Oral Technologies

* Softgel Technologies * Oral Manufacturing * Small Molecule Analytical

* Inhalation

* Small Molecule Injectable

*

Locations

* Asia Pacific

* Europe

* Latin America

* North America

* Site Tours

*

About Us

* Who We Are

* News & Events

* Our Leadership

* Our Scientists

* Investors

* Corporate Responsibility * Diversity & Inclusion

*

Careers

* Working at Catalent

* Why Join Us?

* Career Opportunities CATALENT HAS ACQUIRED DELPHI GENETICS AND LAUNCHES US PLASMID

MANUFACTURING SITE

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to

commercialization

Learn More

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

Learn More

CATALENT ON TRACK TO PRODUCE OVER ONE BILLION DOSES OF COVID-19 VACCINES AND THERAPIES Working on 80+ compounds for 60+ customers across our global network

Learn More

123

CATALENT HAS ACQUIRED DELPHI GENETICS AND LAUNCHES US PLASMID

MANUFACTURING SITE

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to

commercialization

Learn More

Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.

Learn More

CATALENT ON TRACK TO PRODUCE OVER ONE BILLION DOSES OF COVID-19 VACCINES AND THERAPIES Working on 80+ compounds for 60+ customers across our global network

Learn More

123

How can we work together

ORAL

BIOLOGICS

CLINICAL SUPPLY

CONSUMER

Latest News

Hofseth BioCare Announces Global Innovation Partnership with Catalent to Develop Delayed-Release Formulation of OmeGo® Fish Oil CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients.

LEARN MORE

Site Tours

Explore our facilities through new 360° Virtual Site Tours and Site Tour Videos to get a window into our integrated services, superior drug delivery technologies and manufacturing solutions across the

globe.

FLEXDIRECT™ DIRECT-TO-PATIENT SERVICES With the growth in semi and fully remote clinical studies, our flexible direct-to-patient offerings enable clinical supplies to be sent directly to patients’, reducing or eliminating the need for in person clinical site visits.

Global Network

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.

SEE ALL LOCATIONS

North America|Europe|LATAM|APAC|" data-navmenu="off" data-hashurl="off" data-menuslider="off" data-continue-autoplay="on" data-outside-nav="off" data-autoplay="on">

Join Our Team

Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent.

NEWS

* Opportunities and Challenges of Clinical Supply Chain Management in China to be Discussed by Catalent Experts at DIA China 2021 * Catalent Publishes Second Annual Corporate Responsibility Report Highlighting Achievements in an Extraordinary Year for the Pharmaceutical Industry * Hofseth BioCare Announces Global Innovation Partnership with Catalent to Develop Delayed-Release Formulation of OmeGo® Fish Oil * Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing

VIEW ALL NEWS

EVENTS

* ISCT 2021

* ISCCR Digital – Workshop on Clinical Translation * Strategies to Optimize the Dosage Form Design Process to Create

Better Treatments

* Outsourcing in Clinical Trials UK & Ireland

VIEW ALL EVENTS

EXPERT CONTENT

Drug Manufacturing in a Time of Coronavirus Why do new Therapies Succeed or fail in the Marketplace? Elemental Impurities – Guidelines, Testing and Assessments Softgel Technology for Fast-Tracked Development Programs Flexible Manufacturing Strategies: What’s Best for your Product?

VIEW ALL ARTICLES

* Expert Content

* Subscribe

* Investors

* Careers

* Contact Us

* Site Map

* Expert Content

* Subscribe

* Investors

* Careers

* Contact Us

* Site Map

Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy

| Privacy

Shield Statement

| Cookies

Settings .

Copyright 2020, Catalent, Inc – All Rights Reserved Terms  | Modern Slavery Statement

* Expert Content

* Subscribe

* Investors

* Careers

* Contact Us

* Site Map

* Expert Content

* Subscribe

* Investors

* Careers

* Contact Us

* Site Map

Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy

| Privacy

Shield Statement

| Cookies

Settings .

Terms  | Modern Slavery Statement Copyright 2020, Catalent, Inc

All Rights Reserved

COOKIE LIST

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the

following purposes:

TARGETING COOKIES

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

COOKIE SUBGROUP

COOKIES

COOKIES USED

www.facebook.com

3rd Party

doubleclick.net

IDE, test_cookie

3rd Party

linkedin.com

UserMatchHistory

3rd Party

youtube.com

YSC, YTC, GPS

3rd Party

tr.contextweb.com

INGRESSCOOKIE

3rd Party

bh.contextweb.com

INGRESSCOOKIE

3rd Party

ads.linkedin.com

lang

3rd Party

FUNCTIONAL COOKIES

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

COOKIE SUBGROUP

COOKIES

COOKIES USED

japan.catalent.com

eZSESSID578ed5a4eecf5a15803abdc49f6152d6

1st Party

brasil.catalent.com

wordpress_d2e6dc7eb122b4e249c66d61c720b498

,

wordpressuser_d2e6dc7eb122b4e249c66d61c720b498

,

wordpresspass_d2e6dc7eb122b4e249c66d61c720b498

,

wordpress_logged_in_d2e6dc7eb122b4e249c66d61c720b498

,

wordpress_test_cookie

,

wp-settings-time-0

, wp-settings-0

,

wp-postpass_d2e6dc7eb122b4e249c66d61c720b498

1st Party

youtube.com

VISITOR_INFO1_LIVE

3rd Party

cts.businesswire.com

JSESSIONID

3rd Party

SOCIAL MEDIA COOKIES These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these

sharing tools.

COOKIE SUBGROUP

COOKIES

COOKIES USED

linkedin.com

lidc, lang, lissc, bcookie

3rd Party

www.linkedin.com

bscookie

3rd Party

facebook.com

fr

3rd Party

twitter.com

personalization_id

3rd Party

STRICTLY NECESSARY COOKIES These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

COOKIE SUBGROUP

COOKIES

COOKIES USED

auth.catalent.com

pwcount , NSC_PERS

, NSC_TASS

, NSC_USER

, NSC_TEMP

1st Party

latam.catalent.com

AWSALB

1st Party

consumerhealth.catalent.com

products_submit_uri

,

products_selector

,

products_main_selector

1st Party

www.clinical.catalent.com

AWSALBCORS ,

wordpress_test_cookie

1st Party

catalent.com

ELOQUA , _gclxxxx

, _gid

, __utmc

, __utmb

, _ga

, __utma

, __utmz

, __utmt

, OptanonConsent

,

OptanonAlertBoxClosed

,

eupubconsent , _gat

, _utmv#########

1st Party

investor.catalent.com

__cfduid

1st Party

brasil.catalent.com

wordpress_sec_

1st Party

accounts.livechatinc.com __oauth_redirect_detector, __lc_cst, __lc2_cid, __lc2_cst,

__lc_cid

3rd Party

onetrust.com

__cfduid

3rd Party

eloqua.com

ELQSTATUS, ELOQUA

3rd Party

livechatinc.com

__livechat

3rd Party

api.livechatinc.com

CASID

3rd Party

cookielaw.org

__cfduid

3rd Party

PERFORMANCE COOKIES

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor

its performance.

COOKIE SUBGROUP

COOKIES

COOKIES USED

catalent.com

_gat_UA-

1st Party

investor.catalent.com

awxxxx

1st Party

nr-data.net

JSESSIONID

3rd Party

Cookies Settings

PRIVACY PREFERENCE CENTER

*

YOUR PRIVACY

*

TARGETING COOKIES

*

FUNCTIONAL COOKIES

*

SOCIAL MEDIA COOKIES

*

STRICTLY NECESSARY COOKIES

*

PERFORMANCE COOKIES

YOUR PRIVACY

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Cookies Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

Cookies Details‎

SOCIAL MEDIA COOKIES Social Media Cookies These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these

sharing tools.

Cookies Details‎

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor

its performance.

Cookies Details‎

BACK BUTTON BACK

Vendor Search

Filter Button

Consent Leg.Interest checkbox label label checkbox label label checkbox label label

*

33ACROSS

33ACROSS

View Third Party Cookies

*

Name

cookie name

*

33ACROSS

View Privacy Notice

Clear

checkbox label label

Apply Cancel

Confirm My Choices

Allow All

THIS WEBSITE USES COOKIES By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy

.

Accept All CookiesCookies Settings